1Manson JE, Allison MA, Rossouw JE,et al. Estrogen therapy and coronary - artery calcification [ J ]. N Engl J Med, 2007, 356 (25) : 2591 - 2602.
2Bibbins - Domingo K, Lin F, Vittinghoff E, et al. Effect of hormone therapy on mortality rates among women with heart failure and coronary artery disease [ J ]. Am J Cardiol, 2005, 95(2) : 289 -291.
3Mobasseri S, Liebson PR, Klein LW. Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist′s perspective [ J ]. Cardiol Rev, 2004, 12(6) : 287 -298.
4Das B, Sarkar C. Is the sarcolemmal or mitochondrial K (ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model? [ J]. Life Sci, 2005, 77(11) : 1226 -1248.
5Brown DA, Lynch JM, Armstrong C J, et al. Susceptibility of the heart to ischaemia -reperfusion injury and exercise -induced cardioprotection are sex- dependent in the rat [J]. Physiol, 2005, 564(2): 619 -630.
6Hong MK, Romm PA, Reagan K, et al. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women [J]. Am J Cardiol, 1992, 69(2) : 176 - 178.
7Davidge ST, Zhang YL. Estrogen replacement suppresses a prostaglandin H synthase -dependent vasoconstrictor in rat mesenteric arteries [J]. Circ Rea, 1998, 83(4) : 388 -395.
8Wassmann S, Baumer AT, Strehlow K, et al. Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats [ J ]. Circulation, 2001, 103(3) : 435 -441.
